NanoViricides
NNVC
#10341
Rank
S$41.56 M
Marketcap
S$1.81
Share price
4.48%
Change (1 day)
5.04%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of September 2025 : S$9.26 Million

According to NanoViricides's latest financial reports the company has S$9.26 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2025-06-30$S$9.55 M-38.49%
2024-06-30$S$15.53 M-22.73%
2023-06-30$S$20.1 M-37.36%
2022-06-30$S$32.08 M-20.22%
2021-06-30$S$40.22 M32.64%
2020-06-30$S$30.32 M111.61%
2019-06-30$S$14.32 M-40.48%
2018-06-30$S$24.07 M-13.94%
2017-06-30$S$27.97 M-9.9%
2016-06-30$S$31.04 M-27.5%
2015-06-30$S$42.82 M47%
2014-06-30$S$29.13 M186.64%
2013-06-30$S$10.16 M-42.08%
2012-06-30$S$17.54 M40.6%
2011-06-30$S$12.48 M37.89%
2010-06-30$S$9.05 M152.12%
2009-06-30$S$3.59 M494.55%
2008-06-30$S$0.6 M-21.32%
2007-06-30$S$0.76 M-61.06%
2006-06-30$S$1.97 M-1863.72%
2005-06-30$-S$0.12 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
S$30.26 B 326,478.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$59.33 B 640,080.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$25.96 B 280,079.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$29.80 B 321,480.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-S$0.19 Billion-2,117.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.72 Billion-7,819.40%๐Ÿ‡บ๐Ÿ‡ธ USA